Search Results

There are 10257 results for: content related to: A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy

  1. Triptan Education and Improving Knowledge for Optimal Migraine Treatment: An Observational Study

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 4, April 2014, Pages: 686–697, Eric P. Baron, Shira Y. Markowitz, Alyssa Lettich, Eric Hastriter, Brigitte Lovell, Kavita Kalidas, David William Dodick, Todd J. Schwedt and on behalf of the American Headache Society Headache Fellows Research Consortium

    Article first published online : 12 FEB 2014, DOI: 10.1111/head.12286

  2. Identifying the Factors Underlying Discontinuation of Triptans

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 2, February 2014, Pages: 278–289, Rebecca E. Wells, Shira Y. Markowitz, Eric P. Baron, Joseph G. Hentz, Kavita Kalidas, Paul G. Mathew, Rashmi Halker, David W. Dodick and Todd J. Schwedt

    Article first published online : 3 SEP 2013, DOI: 10.1111/head.12198

  3. Education and Decision Making at the Time of Triptan Prescribing: Patient Expectations vs Actual Practice

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 4, April 2014, Pages: 698–708, Paul G. Mathew, Jelena M. Pavlovic, Alyssa Lettich, Rebecca E. Wells, Carrie E. Robertson, Kathleen Mullin, Larry Charleston IV, David W. Dodick and Todd J. Schwedt

    Article first published online : 11 FEB 2014, DOI: 10.1111/head.12308

  4. Treatment Persistence and Switching in Triptan Users: A Systematic Literature Review

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 7, July/August 2014, Pages: 1120–1130, Andrew J. Messali, Mo Yang, Patrick Gillard, Kimberly Tsai, Stewart J. Tepper, Lisa M. Bloudek and Shashidhar H. Kori

    Article first published online : 10 JUN 2014, DOI: 10.1111/head.12404

  5. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 825–839, Dawn C. Buse, Daniel Serrano, Michael L. Reed, Shashi H. Kori, Cedric M. Cunanan, Aubrey Manack Adams and Richard B. Lipton

    Article first published online : 17 APR 2015, DOI: 10.1111/head.12556

  6. Acute Migraine Treatment in Adults

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 778–793, Werner J. Becker

    Article first published online : 15 APR 2015, DOI: 10.1111/head.12550

  7. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue S4, July/August 2015, Pages: 221–235, Chris Cameron, Shannon Kelly, Shu-Ching Hsieh, Meghan Murphy, Li Chen, Ahmed Kotb, Joan Peterson, Doug Coyle, Becky Skidmore, Tara Gomes, Tammy Clifford and George Wells

    Article first published online : 14 JUL 2015, DOI: 10.1111/head.12601

  8. Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study

    Headache: The Journal of Head and Face Pain

    Volume 53, Issue 10, November/December 2013, Pages: 1548–1563, Richard B. Lipton, Daniel Serrano, Robert A. Nicholson, Dawn C. Buse, M. Chris Runken and Michael L. Reed

    Article first published online : 28 AUG 2013, DOI: 10.1111/head.12201

  9. Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans

    Headache: The Journal of Head and Face Pain

    Volume 53, Issue 9, October 2013, Pages: 1415–1429, Daniel Serrano, Dawn C. Buse, Shashi H. Kori, Sypridon Papapetropoulos, Cedric M. Cunanan, Aubrey N. Manack, Michael L. Reed and Richard B. Lipton

    Article first published online : 28 JUN 2013, DOI: 10.1111/head.12164

  10. Pregnancy Outcome Following Prenatal Exposure to Triptan Medications: A Meta-Analysis

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 4, April 2015, Pages: 490–501, Alexander Marchenko, Fatma Etwel, Olukayode Olutunfese, Cheri Nickel, Gideon Koren and Irena Nulman

    Article first published online : 3 FEB 2015, DOI: 10.1111/head.12500

    Corrected by:

    Erratum: Errata

    Vol. 55, Issue 10, 1478, Article first published online: 17 NOV 2015

  11. Public Drug Coverage and Its Impact on Triptan Use Across Canada: A Population-Based Study

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue S4, July/August 2015, Pages: 212–220, Anthony Amadio, Kathy Lee, Zhan Yao, Ximena Camacho, Sandra Knowles, Christine Lay, J. Michael Paterson, Jordan Hunt, Tara Gomes and On behalf of the Ontario Drug Policy Research Network

    Article first published online : 7 MAR 2015, DOI: 10.1111/head.12508

  12. Daily Triptan Use for Intractable Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 1, January 2014, Pages: 155–162, Egilius L.H. Spierings

    Article first published online : 8 JAN 2014, DOI: 10.1111/head.12275

    Corrected by:

    Erratum: Erratum

    Vol. 54, Issue 5, 952, Article first published online: 2 MAY 2014

  13. Access to Triptans for Acute Episodic Migraine: A Qualitative Study

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue S4, July/August 2015, Pages: 199–211, Sobia Khan, Alekhya Mascarenhas, Julia E. Moore, Sandra Knowles and Tara Gomes

    Article first published online : 14 JUL 2015, DOI: 10.1111/head.12593

  14. Association of RAMP1 rs7590387 With the Risk of Migraine Transformation Into Medication Overuse Headache

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 5, May 2015, Pages: 658–668, Sarah Cargnin, Chiara Pautasso, Michele Viana, Grazia Sances, Daniela Mittino, Roberto Cantello, Cristina Tassorelli, Giuseppe Nappi and Salvatore Terrazzino

    Article first published online : 17 APR 2015, DOI: 10.1111/head.12559

  15. Treatment Adherence in Patients With Headache: A Systematic Review

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 5, May 2014, Pages: 795–816, Rachelle R. Ramsey, Jamie L. Ryan, Andrew D. Hershey, Scott W. Powers, Brandon S. Aylward and Kevin A. Hommel

    Article first published online : 17 APR 2014, DOI: 10.1111/head.12353

  16. QT Prolongation, Torsade de Pointes, Myocardial Ischemia From Coronary Vasospasm, and Headache Medications. Part 1: Review of Serotonergic Cardiac Adverse Events With a Triptan Case

    Headache: The Journal of Head and Face Pain

    Volume 53, Issue 1, January 2013, Pages: 208–216, Mark J. Stillman, Stewart Tepper, Deborah E. Tepper and Leslie Cho

    Article first published online : 6 DEC 2012, DOI: 10.1111/j.1526-4610.2012.02300.x

    Corrected by:

    Erratum: Erratum

    Vol. 53, Issue 3, 579–580, Article first published online: 13 MAR 2013

  17. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 885–916, Eric P. Baron

    Article first published online : 25 MAY 2015, DOI: 10.1111/head.12570

  18. Triptans: low utilization and high turnover in the general population

    Cephalalgia

    A Panconesi, E Pavone, M Franchini, N Mennuti, ML Bartolozzi, L Guidi and R Banfi

    Article first published online : 3 SEP 2009, DOI: 10.1111/j.1468-2982.2009.02001.x

  19. You have free access to this content
    Why Triptan Treatment Can Fail: Focus on Gastrointestinal Manifestations of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 53, Issue S1, June 2013, Pages: 11–16, Lawrence C. Newman

    Article first published online : 30 MAY 2013, DOI: 10.1111/head.12111

  20. Triptans for Acute Migraine: Drug Class Review to Help Inform Policy Decisions

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue S4, July/August 2015, Pages: 191–198, Sandra Knowles, Paul Oh, Tara Gomes and On behalf of theOntario Drug Policy Research Network

    Article first published online : 14 JUL 2015, DOI: 10.1111/head.12594